CORC

在结果中检索

CORC

浏览/检索结果: 共10条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Lu, Shun;  Wu, Yi-Long;  Huang, Yunchao;  Hu, Cheng-Ping;  Li, Wei
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Zhang, Li;  Cseh, Agnieszka;  Peil, Barbara;  Wang, Jie;  Feng, Jifeng
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 卷号: 13, 期号: 1
作者:  Li, Xiaomei;  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 期刊论文
BRITISH JOURNAL OF CANCER, 2017, 卷号: 116, 期号: 2
作者:  Wu, Yi-Long;  Sequist, Lecia V.;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6
作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial 期刊论文
LANCET ONCOLOGY, 2014, 卷号: 15, 期号: 2
作者:  Geater, Sarayut L.;  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 会议论文
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFRM plus ) advanced adenocarcinoma of the lung 期刊论文
EUROPEAN RESPIRATORY JOURNAL, 2013, 卷号: 42
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
bcr/abl反义寡聚脱氧核苷酸抑制慢性粒细胞白血病细胞生长的研究 期刊论文
吉林大学学报(医学版), 2005, 期号: 3
作者:  袁长吉,黄凤飞,姚程,易永林
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace